Hypertension Clinical Trial
Official title:
Effect of a Multi-component Education Program on Salt Reduction in Adults
Verified date | January 2020 |
Source | Academia Cuf Descobertas |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Excess salt intake is a major contributor to high blood pressure, the leading individual risk
factor for cardiovascular events, such as stroke, myocardial infarction and heart failure.
According to PHYSA study, salt intake in Portugal remains much higher (10.7 g) than
recommended by the international health organisations, indicating the need for effective
implementation of salt reduction interventions. In Portugal the main source of daily salt
intake is added salt during cooking, and salt content in bread, cheese and processed meat.
The objective of this study is to determine the effectiveness of a dietary education program
tailored for salt reduction. To assess the effectiveness of the salt reduction program the
investigator's will measure changes in salt consumption levels, by evaluating the 24 h
urinary sodium excretion.
This study is a consortium-initiated, randomised, simple-blinded, controlled trial designed
to assess the effectiveness of a salt reduction program versus generic healthy lifestyle
program in the Lisbon Metropolitan Area.
Status | Completed |
Enrollment | 311 |
Est. completion date | September 6, 2019 |
Est. primary completion date | September 6, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Adults between the ages of 20 and 70. - Subjects with or without hypertension, not medicated or medicated with medication and diet stabilized for at least 3 weeks. - Responsible for the purchase and confection of their meals. - Available to comply with study protocol and sign informed consent. Exclusion Criteria: - Pregnant, breastfeeding or planning to become pregnant within the study period. - Subjects with current or previous cardiovascular disease (ischemic cardiovascular disease, angina stable or unstable; myocardial infarction, stroke or symptomatic peripheral arteriosclerosis). - Subjects with liver or kidney diseases or cancer. - Subjects with history of drug, alcohol or other substances abuse, or other factors limiting their ability to cooperate during the study. - Subjects with special dietary needs. - Health condition that prevents compliance with study requirements. |
Country | Name | City | State |
---|---|---|---|
Portugal | Hospital CUF Descobertas | Lisbon | |
Portugal | Hospital CUF Infante Santo | Lisbon |
Lead Sponsor | Collaborator |
---|---|
Academia Cuf Descobertas | CUF Academic and Research Medical Center, José de Mello Saúde, NOVA Medical School, Pingo Doce |
Portugal,
Polonia J, Lobo MF, Martins L, Pinto F, Nazare J. Estimation of populational 24-h urinary sodium and potassium excretion from spot urine samples: evaluation of four formulas in a large national representative population. J Hypertens. 2017 Mar;35(3):477-486. doi: 10.1097/HJH.0000000000001180. — View Citation
Polonia J, Martins L, Pinto F, Nazare J. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study. J Hypertens. 2014 Jun;32(6):1211-21. doi: 10.1097/HJH.0000000000000162. — View Citation
Polonia J, Monteiro J, Almeida J, Silva JA, Bertoquini S. High salt intake is associated with a higher risk of cardiovascular events: a 7.2-year evaluation of a cohort of hypertensive patients. Blood Press Monit. 2016 Oct;21(5):301-6. doi: 10.1097/MBP.0000000000000205. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in 24-hour urinary sodium excretion | Difference between the intervention and control group in the change in 24-hour urinary sodium excretion from baseline to the end of follow-up. | 12 weeks | |
Secondary | Change in systolic and diastolic blood pressure | Difference between the intervention and control group in the change in systolic and diastolic blood pressure from baseline to the end of follow-up. | 12 week | |
Secondary | Change in weight | Difference between the intervention and control group in the change of weight from baseline to the end of follow-up. | 12 week | |
Secondary | Change in waist circumference | Difference between the intervention and control group in the change of waist circumference from baseline to the end of follow-up. | 12 week | |
Secondary | Change in salt content in foods purchased | Difference between the intervention and control group in the change of salt content in foods purchased from baseline to the end of follow-up. | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |